FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3192986904> ?p ?o ?g. }

• W3192986904 endingPage "2870" @default.
• W3192986904 startingPage "2861" @default.
• W3192986904 abstract "Is there a relationship between serum and endometrial progesterone (P4) levels, including P4 and metabolites (oestrone, oestradiol and 17α-hydroxyprogesterone), and endometrial receptivity?Serum P4 levels were not correlated with endometrial P4, nor associated with endometrial receptivity as determined by the ERA® test; however, endometrial P4 and 17α-hydroxyprogesterone levels were positively correlated and related to endometrial receptivity by ERA.Acquisition of endometrial receptivity is governed by P4, which induces secretory transformation. A close relationship between serum P4 and pregnancy outcome is reported for hormone replacement therapy (HRT) cycles. However, the relationship between serum and uterine P4 levels has not been described, and it is unknown whether uterine receptivity depends more on serum or uterine P4 levels.A prospective cohort study was performed during March 2018-2019 in 85 IVF patients undergoing an evaluation-only HRT cycle with oestradiol valerate (6 mg/day) and micronised vaginal progesterone (400 mg/12 h).Patients were under 50 years of age, had undergone at least one failed IVF cycle, had no uterine pathology, and had adequate endometrial thickness (> 6.5 mm). The study was conducted at IVI Valencia and IVI Foundation. An endometrial biopsy and a blood sample were collected after 5 days of P4 vaginal treatment. Measures included serum P4 levels, ERA®-based evaluation of endometrial receptivity, and endometrial P4 levels along with metabolites (oestrone, oestradiol and 17α-hydroxyprogesterone) measured by ultra-performance liquid chromatography-tandem mass spectrometry.Seventy-nine women were included (mean age: 39.9 ± 4.6, BMI: 24.2 ± 3.9 kg/m2, endometrial thickness: 8.2 ± 1.4 mm). The percentage of endometria indicated as receptive by ERA® was 40.5%. When comparing receptive versus non-receptive groups, no differences were observed in baseline characteristics nor in steroid hormones levels in serum or endometrium. No association between serum P4 and endometrial steroid levels or ERA result was found (P < 0.05). When the population was stratified according to metabolite concentration levels, endometrial P4 and 17α-hydroxyprogesterone were significantly associated with endometrial receptivity (P < 0.05). A higher proportion of receptive endometria by ERA was observed when endometrial P4 levels were higher than 40.07 µg/ml (relative maximum) and a lower proportion of receptive endometria was associated with endometrial 17α-hydroxyprogesterone lower than 0.35 ng/ml (first quartile). A positive correlation R2 = 0.67, P < 0.001 was observed between endometrial P4 and 17α-hydroxyprogesterone levels.This study did not analyse pregnancy outcomes. Further, the findings can only be extrapolated to HRT cycles with micronised vaginal progesterone for luteal phase support.Our findings suggest that the combined benefits of different routes of progesterone administration for luteal phase support could be leveraged to ensure an adequate concentration of progesterone both in the uterus and in the bloodstream. Further studies will confirm whether this method can optimise both endometrial receptivity and live birth rate. Additionally, targeted treatment to increase P4 endometrial levels may normalise the timing of the window of implantation without needing to modify the progesterone administration day.This research was supported by the IVI-RMA Valencia (1706-VLC-051-EL) and Consellería d'Educació, Investigació, Cultura, i esport Generalitat Valenciana (Valencian Government, Spain, GV/2018//151). Almudena Devesa-Peiro (FPU/15/01398) and Cristina Rodriguez-Varela (FPU18/01657) were supported by the FPU program fellowship from the Ministry of Science, Innovation and Universities (Spanish Government). P.D.-G. is co-inventor on the ERA patent, with non-economic benefits. The other authors have no competing interests.NCT03456375." @default.
• W3192986904 created "2021-08-16" @default.
• W3192986904 creator A5010192662 @default.
• W3192986904 creator A5019671119 @default.
• W3192986904 creator A5028171481 @default.
• W3192986904 creator A5030614205 @default.
• W3192986904 creator A5039941652 @default.
• W3192986904 creator A5056265492 @default.
• W3192986904 creator A5076215079 @default.
• W3192986904 creator A5079179603 @default.
• W3192986904 creator A5090097460 @default.
• W3192986904 date "2021-08-12" @default.
• W3192986904 modified "2023-10-16" @default.
• W3192986904 title "Analysis of serum and endometrial progesterone in determining endometrial receptivity" @default.
• W3192986904 cites W1512555213 @default.
• W3192986904 cites W1978918749 @default.
• W3192986904 cites W1995603243 @default.
• W3192986904 cites W2011764393 @default.
• W3192986904 cites W2036334470 @default.
• W3192986904 cites W2069902854 @default.
• W3192986904 cites W2084669890 @default.
• W3192986904 cites W2102599346 @default.
• W3192986904 cites W2111925739 @default.
• W3192986904 cites W2124156734 @default.
• W3192986904 cites W2143750395 @default.
• W3192986904 cites W2153407128 @default.
• W3192986904 cites W2166502991 @default.
• W3192986904 cites W2169827333 @default.
• W3192986904 cites W2743164141 @default.
• W3192986904 cites W2753371216 @default.
• W3192986904 cites W2763505512 @default.
• W3192986904 cites W2790395560 @default.
• W3192986904 cites W2792572687 @default.
• W3192986904 cites W2801620514 @default.
• W3192986904 cites W2890204348 @default.
• W3192986904 cites W2894914503 @default.
• W3192986904 cites W2910025422 @default.
• W3192986904 cites W2928102535 @default.
• W3192986904 cites W2936770777 @default.
• W3192986904 cites W2949360232 @default.
• W3192986904 cites W2965741381 @default.
• W3192986904 cites W2975890503 @default.
• W3192986904 cites W3008183745 @default.
• W3192986904 cites W3034705880 @default.
• W3192986904 cites W3087826547 @default.
• W3192986904 cites W3090331587 @default.
• W3192986904 cites W3114892659 @default.
• W3192986904 cites W3128610165 @default.
• W3192986904 cites W4246694395 @default.
• W3192986904 cites W4297084741 @default.
• W3192986904 cites W84583857 @default.
• W3192986904 doi "https://doi.org/10.1093/humrep/deab184" @default.
• W3192986904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34382075" @default.
• W3192986904 hasPublicationYear "2021" @default.
• W3192986904 type Work @default.
• W3192986904 sameAs 3192986904 @default.
• W3192986904 citedByCount "29" @default.
• W3192986904 countsByYear W31929869042021 @default.
• W3192986904 countsByYear W31929869042022 @default.
• W3192986904 countsByYear W31929869042023 @default.
• W3192986904 crossrefType "journal-article" @default.
• W3192986904 hasAuthorship W3192986904A5010192662 @default.
• W3192986904 hasAuthorship W3192986904A5019671119 @default.
• W3192986904 hasAuthorship W3192986904A5028171481 @default.
• W3192986904 hasAuthorship W3192986904A5030614205 @default.
• W3192986904 hasAuthorship W3192986904A5039941652 @default.
• W3192986904 hasAuthorship W3192986904A5056265492 @default.
• W3192986904 hasAuthorship W3192986904A5076215079 @default.
• W3192986904 hasAuthorship W3192986904A5079179603 @default.
• W3192986904 hasAuthorship W3192986904A5090097460 @default.
• W3192986904 hasConcept C126322002 @default.
• W3192986904 hasConcept C16685009 @default.
• W3192986904 hasConcept C2776606343 @default.
• W3192986904 hasConcept C2779742232 @default.
• W3192986904 hasConcept C29456083 @default.
• W3192986904 hasConcept C42407357 @default.
• W3192986904 hasConcept C71924100 @default.
• W3192986904 hasConceptScore W3192986904C126322002 @default.
• W3192986904 hasConceptScore W3192986904C16685009 @default.
• W3192986904 hasConceptScore W3192986904C2776606343 @default.
• W3192986904 hasConceptScore W3192986904C2779742232 @default.
• W3192986904 hasConceptScore W3192986904C29456083 @default.
• W3192986904 hasConceptScore W3192986904C42407357 @default.
• W3192986904 hasConceptScore W3192986904C71924100 @default.
• W3192986904 hasFunder F4320315062 @default.
• W3192986904 hasIssue "11" @default.
• W3192986904 hasLocation W31929869041 @default.
• W3192986904 hasLocation W31929869042 @default.
• W3192986904 hasOpenAccess W3192986904 @default.
• W3192986904 hasPrimaryLocation W31929869041 @default.
• W3192986904 hasRelatedWork W1973330954 @default.
• W3192986904 hasRelatedWork W1974135102 @default.
• W3192986904 hasRelatedWork W1988322245 @default.
• W3192986904 hasRelatedWork W2003387008 @default.
• W3192986904 hasRelatedWork W2017451019 @default.
• W3192986904 hasRelatedWork W2129255493 @default.
• W3192986904 hasRelatedWork W2620587867 @default.
• W3192986904 hasRelatedWork W2998856808 @default.

• next